Celcuity’s Q2 2026 Performance: Share Gains, Zero Gearing, and Strategic Focus
Celcuity Inc. reports a volatile yet strategically disciplined first half of 2026, with rising share price, zero gearing, and a focus on solid‑tumor therapies.
2 minutes to read

